Lpl Financial LLC Exelixis, Inc. Transaction History
Lpl Financial LLC
- $238 Billion
- Q4 2024
A detailed history of Lpl Financial LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 107,212 shares of EXEL stock, worth $3.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
107,212
Previous 84,842
26.37%
Holding current value
$3.95 Million
Previous $2.2 Million
62.2%
% of portfolio
0.0%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding EXEL
# of Institutions
564Shares Held
251MCall Options Held
1.45MPut Options Held
1.13M-
Black Rock Inc. New York, NY33.5MShares$1.23 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.4MShares$1.08 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA23.4MShares$864 Million4.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.3MShares$564 Million0.8% of portfolio
-
State Street Corp Boston, MA11.4MShares$421 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.9B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...